[{"Assets_0_Q2_USD":238974000.0,"CommonStockSharesOutstanding_0_Q2_shares":45854213.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-36592000.0,"NetIncomeLoss_1_Q2_USD":-28090000.0,"NetIncomeLoss_2_Q2_USD":-45760000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":45409588.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":44970831.0,"StockholdersEquity_0_Q2_USD":196646000.0,"Ticker":"RCUS","CIK":"1724521","name":"ARCUS BIOSCIENCES, INC.","OfficialName":"Arcus Biosciences Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2226368293.0","Country":"nan","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20190806"}]